Going circular: history, present, and future of circRNAs in cancer
To date, thousands of highly abundant and conserved single-stranded RNA molecules shaped into ring structures (circRNAs) have been identified. CircRNAs are multifunctional molecules that have been shown to regulate gene expression transcriptionally and post-transcriptionally and exhibit distinct tissue- and development-specific expression patterns associated with a variety of normal and disease conditions, including cancer pathogenesis. Over the past years, due to their intrinsic stability and resistance to ribonucleases, particular attention has been drawn to their use as reliable diagnostic and prognostic biomarkers in cancer diagnosis, treatment, and prevention. However, there are some critical caveats to their utility in the clinic. Their circular shape limits their annotation and a complete functional elucidation is lacking. This makes their detection and biomedical application still challenging. Herein, we review the current knowledge of circRNA biogenesis and function, and of their involvement in tumorigenesis and potential utility in cancer-targeted therapy.
Top-30
Journals
|
1
2
3
4
5
6
7
8
9
|
|
|
International Journal of Molecular Sciences
9 publications, 5.2%
|
|
|
Non-coding RNA Research
4 publications, 2.31%
|
|
|
Pathology Research and Practice
4 publications, 2.31%
|
|
|
Frontiers in Oncology
4 publications, 2.31%
|
|
|
Molecular Cancer
4 publications, 2.31%
|
|
|
Cell Death and Disease
4 publications, 2.31%
|
|
|
Discover Oncology
4 publications, 2.31%
|
|
|
Scientific Reports
3 publications, 1.73%
|
|
|
Cells
3 publications, 1.73%
|
|
|
International Journal of Biological Macromolecules
3 publications, 1.73%
|
|
|
Frontiers in Immunology
3 publications, 1.73%
|
|
|
Cancer Cell International
3 publications, 1.73%
|
|
|
Non-coding RNA
2 publications, 1.16%
|
|
|
Medical Oncology
2 publications, 1.16%
|
|
|
Frontiers in Genetics
2 publications, 1.16%
|
|
|
Critical Reviews in Oncology/Hematology
2 publications, 1.16%
|
|
|
BMC Genomics
2 publications, 1.16%
|
|
|
Oncogene
2 publications, 1.16%
|
|
|
Cancer Drug Resistance
2 publications, 1.16%
|
|
|
Cell Death Discovery
2 publications, 1.16%
|
|
|
Clinica Chimica Acta
2 publications, 1.16%
|
|
|
Gene
2 publications, 1.16%
|
|
|
Life Sciences
2 publications, 1.16%
|
|
|
Biochemical Pharmacology
2 publications, 1.16%
|
|
|
Biomedicine and Pharmacotherapy
2 publications, 1.16%
|
|
|
Cellular and Molecular Biology Letters
2 publications, 1.16%
|
|
|
Naunyn-Schmiedeberg's Archives of Pharmacology
2 publications, 1.16%
|
|
|
Advances in Experimental Medicine and Biology
2 publications, 1.16%
|
|
|
Redox Biology
1 publication, 0.58%
|
|
|
1
2
3
4
5
6
7
8
9
|
Publishers
|
10
20
30
40
50
60
|
|
|
Springer Nature
56 publications, 32.37%
|
|
|
Elsevier
41 publications, 23.7%
|
|
|
MDPI
22 publications, 12.72%
|
|
|
Frontiers Media S.A.
16 publications, 9.25%
|
|
|
Wiley
13 publications, 7.51%
|
|
|
Spandidos Publications
4 publications, 2.31%
|
|
|
Taylor & Francis
4 publications, 2.31%
|
|
|
Bentham Science Publishers Ltd.
2 publications, 1.16%
|
|
|
OAE Publishing Inc.
2 publications, 1.16%
|
|
|
American Chemical Society (ACS)
2 publications, 1.16%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
2 publications, 1.16%
|
|
|
BMJ
1 publication, 0.58%
|
|
|
Oxford University Press
1 publication, 0.58%
|
|
|
Moffitt Cancer Center
1 publication, 0.58%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 0.58%
|
|
|
Pleiades Publishing
1 publication, 0.58%
|
|
|
SAGE
1 publication, 0.58%
|
|
|
Portland Press
1 publication, 0.58%
|
|
|
Apex Publishing
1 publication, 0.58%
|
|
|
10
20
30
40
50
60
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.